id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2676228,d182e680-646c-4cd3-a3d9-e66ea27d66b4,Q3,MICHAEL YAKI CONSULTING,401105649,ANTIMICROBIALS WORKING GROUPS,2021,third_quarter,MMM,Discuss w House and Senate staff on funding for antimicrobial commercialization,"HOUSE OF REPRESENTATIVES,SENATE",30000,,0,0,2021-10-04T16:46:29.620000-04:00